相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia A 12-Month Phase 3 Study
Bruce S. Spinowitz et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Safety evaluation and cardiovascular effect of additional use of spironolactone in hemodialysis patients: a meta-analysis
Qing Zeng et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Dyskalemia in Chronic Kidney Disease: How Concerned Should We Be?
Srijan Tandukar et al.
NEPHRON (2018)
Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease
Katherine G. Garlo et al.
JAMA NETWORK OPEN (2018)
Patterns of use and impact of standardised MedDRA query analyses on the safety evaluation and review of new drug and biologics license applications
Lin-Chau Chang et al.
PLOS ONE (2017)
Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes
Sarah Gilligan et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2017)
Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety
Andrew S. Bomback
BLOOD PURIFICATION (2016)
Sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia
Zubaid Rafique et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease The AMETHYST-DN Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient
Stephen R. Ash et al.
KIDNEY INTERNATIONAL (2015)
Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
Matthew R. Weir et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sodium Zirconium Cyclosilicate in Hyperkalemia
David K. Packham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Current Status of Bicarbonate in CKD
Mirela Dobre et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Novel Agents for the Prevention and Management of Hyperkalemia
Peter A. McCullough et al.
REVIEWS IN CARDIOVASCULAR MEDICINE (2015)
Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia The HARMONIZE Randomized Clinical Trial
Mikhail Kosiborod et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Characterization of Structure and Function of ZS-9, α K+ Selective Ion Trap
Fiona Stavros et al.
PLOS ONE (2014)
Metabolic acidosis and the progression of chronic kidney disease
Wei Chen et al.
BMC NEPHROLOGY (2014)
2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Treatment of chronic kidney disease
Jeffrey M. Turner et al.
KIDNEY INTERNATIONAL (2012)
Severe hyperkalemia requiring hospitalization: predictors of mortality
Jung Nam An et al.
CRITICAL CARE (2012)
The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
Lisa M. Einhorn et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
分享论文
